Tech Company Financing Transactions

Forma Therapeutics Funding Round

On 12/1/2009, Forma Therapeutics secured $25.5 million in Series B financing from Lilly Ventures, Edbi and Novartis Venture Fund.

Transaction Overview

Company Name
Announced On
12/1/2009
Transaction Type
Venture Equity
Amount
$25,500,000
Round
Series B
Investors

Lilly Ventures (Lead Investor) (Steven Hall)

Edbi

Novartis Venture Fund (Steven Tregay)

Proceeds Purpose
"With this new funding, FORMA will focus on advancing our internal target-based oncology programs and in parallel, we will continue to pursue non-dilutive collaborations to further build our integrated drug discovery platform," said Steven Tregay, CEO of FORMA.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Arsenal St. 100
Watertown, MA 02472
USA
Email Address
Overview
FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas.
Profile
Forma Therapeutics LinkedIn Company Profile
Social Media
Forma Therapeutics Company Twitter Account
Company News
Forma Therapeutics News
Facebook
Forma Therapeutics on Facebook
YouTube
Forma Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Lee
  Frank Lee LinkedIn Profile  Frank Lee Twitter Account  Frank Lee News  Frank Lee on Facebook
Chief Financial Officer
Todd Shegog
  Todd Shegog LinkedIn Profile  Todd Shegog Twitter Account  Todd Shegog News  Todd Shegog on Facebook
Chief Medical Officer
Patrick Kelly
  Patrick Kelly LinkedIn Profile  Patrick Kelly Twitter Account  Patrick Kelly News  Patrick Kelly on Facebook
Vice President
Paul Ehrlich
  Paul Ehrlich LinkedIn Profile  Paul Ehrlich Twitter Account  Paul Ehrlich News  Paul Ehrlich on Facebook
Vice President
Brian Lesser
  Brian Lesser LinkedIn Profile  Brian Lesser Twitter Account  Brian Lesser News  Brian Lesser on Facebook
Vice President
Jonathan O'Connell
  Jonathan O'Connell LinkedIn Profile  Jonathan O'Connell Twitter Account  Jonathan O'Connell News  Jonathan O'Connell on Facebook
VP - Bus. Development
Scott Boyle
  Scott Boyle LinkedIn Profile  Scott Boyle Twitter Account  Scott Boyle News  Scott Boyle on Facebook
VP - General Counsel
Jeannette Potts
  Jeannette Potts LinkedIn Profile  Jeannette Potts Twitter Account  Jeannette Potts News  Jeannette Potts on Facebook
VP - Human Resources
Mary Wadlinger
  Mary Wadlinger LinkedIn Profile  Mary Wadlinger Twitter Account  Mary Wadlinger News  Mary Wadlinger on Facebook
VP - Manufacturing
Suresh Babu
  Suresh Babu LinkedIn Profile  Suresh Babu Twitter Account  Suresh Babu News  Suresh Babu on Facebook
VP - R & D
Frances Duffy-Warren
  Frances Duffy-Warren LinkedIn Profile  Frances Duffy-Warren Twitter Account  Frances Duffy-Warren News  Frances Duffy-Warren on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/1/2009: Aquantia venture capital transaction
Next: 12/2/2009: Vizu venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary